Search results
Diagnosing Psoriatic Arthritis for the Dermatologist
Medscape· 6 days agoEditor's note: Drs Gottlieb and Merola refer to the following presentation throughout their discussion: Masterclasses in Dermatology™: Masterclass in ...
Guselkumab Provides Long-Term Relief From PsA Symptoms
Medscape· 6 days agoGuselkumab improved joint swelling, spinal pain, skin symptoms, and overall disease activity in a...
Worldwide Prevalence of PsA: Meta-Analysis Sheds Light
Medscape· 2 weeks agoPsA is more prevalent in Europe and North America than in Asia and South America, according to a meta-analysis that assessed the worldwide PsA prevalence.
Don't Miss Out - Join the 7th IFPA Conference: Uncovering the Broad Spectrum of Psoriatic Disease
WTNH-TV New Haven· 2 weeks agoIFPA is delighted to announce the 7th IFPA Conference set to take place from June 27th to June 29th,...
Alvotech and Teva Announce U.S. FDA Approval of SELARSDI™ (ustekinumab-aekn), biosimilar to Stelara®...
Morningstar· 7 days agoFood and Drug Administration (FDA) has approved SELARSDI (ustekinumab-aekn) injection for subcutaneous use, as a biosimilar to Stelara®, for the treatment of moderate to severe plaque psoriasis ...
Stelara biosimilar from Alvotech, Teva approved by FDA
BioPharma Dive via Yahoo Finance· 6 days agoThe FDA cleared Selarsdi for treatment of moderate to severe plaque psoriasis and active psoriatic ...
Plaque psoriasis plagues Marietta man for over 30 years until new treatment
WAGA fox local articles via Yahoo News· 1 week agoGreg Morrison of Marietta has been struggling with plaque psoriasis and psoriatic arthritis for more than 30 years. Four months ago, he found a new treatment ...
FDA Approves Second Ustekinumab Biosimilar
Medscape· 6 days agoThe biosimilar is expected to be marketed in the United States on or after February 21, 2025.
MoonLake and Komodo sign 3-year deal for health analytics tech
FierceBiotech· 2 weeks agoMoonLake’s pipeline is directed primarily at inflammatory conditions. The biotech's new partnership...
Sub-Q Tocilizumab Gives Durable Long-Term Responses in JIA
Medscape· 2 weeks agoPatients with juvenile idiopathic arthritis achieved long-term disease control with subcutaneous...